Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 6, 2022; 10(28): 10077-10084
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10077
Table 1 National Institutes of Health Stroke Scale score compared between the two at different time points (mean ± SD)
Groups
n
Before the operation
24 h after the operation
7 d after the operation
Before discharge
Endovascular treatment group5016.43 ± 6.3412.23 ± 5.6310.35 ± 4.016.83 ± 1.23
Medical treatment group5017.09 ± 5.9814.11 ± 6.0312.38 ± 5.228.23 ± 2.09
t value1.0234.5227.09313.12
P value0.2760.0420.0240.001
Table 2 Incidence of early deterioration of neurological function, n (%)
Groups
n
Repeated vascular occlusion
Tissue edema
Cerebral hemorrhage
Overall incidence
Endovascular treatment503 (6.0)1 (2.0)0 (0.0)4 (8.0)
Medical treatment group505 (10.0)3 (6.0)1 (2.0)9 (18.0)
χ2 value9.234
P value0.001
Table 3 Comparison of the modified Rankin scale and activity of daily living scores between the two groups (mean ± SD)
Groups
n
mRS score
ADL score
Endovascular treatment504.11 ± 0.2459.93 ± 15.73
Medical treatment group505.09 ± 0.8346.71 ± 16.22
t value6.1725.522
P value0.0310.035